Iofina PLCa specialist in the exploration and production of iodine and manufacturer of specialty chemical products, announces its audited full-year results for the 12 months to 31 December 2025 (the “Period”).
Growth in iodine production, reflected in increased sales of crystalline iodine, drove 22% revenue growth:
- Revenue of $66.5 million (2024: $54.5 million); Increase of 22%; Eighth consecutive year of growth
- Crystalline iodine sales increase 42% to $35.0 million (2024: $24.7 million)
- Iodine derivatives sales up 5% to $17.8m (2024: $16.9m)
- Crystalline iodine production increased by 109MT (17%) to 743MT (2024: 634.1MT)
- Gross profit of $18.0m (2024: $13.2m); 36% increase
- Adjusted EBITDA1 of $11.8 million (2024: $7.6 million); 56% increase
- Operating profit of $8.7 million (2024: $5.0 million); 74% increase
- profit before tax of $8.4 million (2024: $4.8 million); 75% increase
Strong balance sheet and further growth in net cash position:
- $11.7 million cash at year end (2024: $6.9 million)
- Net cash increased $2.3 million from $2.9 million to $5.2 million
- Average realized iodine price for the year increased 8% to $74.02/kg
Investment for development:
- The ongoing commitment of capital investment for new iodine plants and Iofina chemical processes was $8.4 million in 2025 (2024: $9.5 million).
- An agreement was signed with Western Midstream Partners in December 2025 for a large iodine, IOsorb® production facility in the Permian Basin.
- The Permian Basin plant is expected to be operational in the third quarter of 2026, becoming the group’s fourth new plant in four years
- Strategic focus on establishing a new core field in the Permian Basin to complement the Oklahoma core fields to further optimize IOsorb® processes
- Increasing capacity by building multiple, larger IOsorb® plants and accelerating the roll-out of these facilities to increase iodine production marks a step-change in the Group’s ambitions.
- Permian Basin close to achieving 1000MT crystalline iodine production on annual basis after plant comes online
2026 till now:
- Strong start to 2026, with production of 178.9Mt of crystalline iodine from Iofina’s eight IoSorb® plants in Q1 2026 (Q1 2025: 124.1Mt)
- The company estimates H1 2026 crystalline iodine production to be in the region of 385MT, an upgrade from 325MT-355MT.
- Demand for Iofina’s crystalline iodine remains strong, with the global spot price of iodine consistently above $70/kg, and prices expected to remain stable through the second half of 2026.
- The first plant in the Permian Basin is currently under construction, expected to be delivered on time and on budget
1See Consolidated Statement of Comprehensive Income for calculations
Commenting, President and CEO, Dr. Tom Baker said:
“In 2025, Iofina delivered record revenues for the eighth consecutive year with record iodine production and EBITDA, driven by crystalline iodine sales, high pricing, strong demand and continued operational execution, with IO#11 commissioned in Q3 2025.
“At the end of the period, we announced our expansion into the Permian Basin with the addition of a large-scale IOsorb® plant, marking the next step in our transformational plant growth strategy. This transition toward multiple, larger plants is expected to drive further efficiencies and materially increase production capacity. Our strong balance sheet and cash flow continue to provide the financial flexibility to grow while maintaining disciplined capital allocation.
“Following a strong start to 2026, we have lifted the top end of our H1 2026 production guidance and now expect H1 2026 production to be in the region of 385MT. The company has a clear short-term path to surpass 1,000MT of annual production and grow to over 2,000MT through the development of larger scale plants in the coming years.
“The capital-efficient nature of this model, supported by the strong demand for iodine and the Company’s range of specialty products, reinforces the Board’s confidence in delivering a sustainable, long-term growth strategy for Iofina’s shareholders.”
investor presentation
The Group has announced that Dr Tom Baker, Chief Executive Officer and Malcolm Levin, Chief Financial Officer, will hold an investor presentation and Q&A session via the Investor Meet Company platform on Wednesday, 13 May 2026 at 2:30pm BST. audited Results for the twelve months ended 31 December 2025.
The presentation is open to all existing and potential shareholders. Investors can sign up for free at Investor Meet Company:
https://www.investormeetcompany.com/iofina-plc/register-investor
Investors who follow Iofina on the Investor Meet Company platform will be automatically invited.
For more information, please email: iofina@yellowjerseypr.com
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law based on the European Union (Withdrawal) Act 2018.
Inquiry:
Iofina PLC
Dr. Tom Baker
CEO and President
Phone: +44 (0)20 3006 3135
Nomads and Brokers:
Canaccord Genuity Limited
Henry Fitzgerald-O’Connor/Harry Rees
Phone: +44 (0)20 7523 8000
Financial PR and Media Contacts:
Yellow Jersey PR Ltd
Charles Goodwin/Shivantha Thambirajah/Maya Brooks
Phone: +44 (0)7747 788 221/+44 (0)7983 521 488
iofina@yellowjerseypr.com
About Iofina:
Iofina PLC (AIM: IOF) is a vertically integrated company that specializes in the production of iodine and specialty chemical products. Iofina is the second largest producer of iodine in North America and operates manufacturing units Iofina Resources and Iofina Chemical.
LEI:213800QDMFYVRJYYTQ84
ISIN:GB00B2QL5C79
Iofina Resources
Iofina Resources develops, builds, owns and operates iodine extraction plants using Iofina’s WET® IOsort® technology. Iofina operates eight IOsorb® plants in Oklahoma and continuously uses technology and innovation to improve and expand its operations.
iofina chemicals
Iofina Chemical manufactures high quality halogenated specialty chemicals as well as non-iodine-based products derived from raw iodine. Iofina Chemical celebrates its 40th anniversaryth Anniversary in 2023 as a leading halogen-based specialty chemicals company.
